JAZZ logo

Jazz Pharmaceuticals (JAZZ) Current assets

annual current assets:

$4.63B+$1.19B(+34.74%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual total current assets is $4.63 billion, with the most recent change of +$1.19 billion (+34.74%) on December 31, 2024.
  • During the last 3 years, JAZZ annual current assets has risen by +$2.02 billion (+77.27%).
  • JAZZ annual current assets is now at all-time high.

Performance

JAZZ Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

quarterly current assets:

$4.13B-$501.21M(-10.83%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly total current assets is $4.13 billion, with the most recent change of -$501.21 million (-10.83%) on March 1, 2025.
  • Over the past year, JAZZ quarterly current assets has increased by +$587.92 million (+16.61%).
  • JAZZ quarterly current assets is now -10.83% below its all-time high of $4.63 billion, reached on December 31, 2024.

Performance

JAZZ quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

JAZZ Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+34.7%+16.6%
3 y3 years+77.3%+65.1%
5 y5 years+183.9%+172.0%

JAZZ Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+77.6%-10.8%+65.1%
5 y5-yearat high+183.9%-10.8%+172.0%
alltimeall timeat high>+9999.0%-10.8%>+9999.0%

JAZZ Current assets History

DateAnnualQuarterly
Mar 2025
-
$4.13B(-10.8%)
Dec 2024
$7.38B(-7.2%)
$4.63B(+5.4%)
Sep 2024
-
$4.39B(+19.3%)
Jun 2024
-
$3.68B(+4.0%)
Mar 2024
-
$3.54B(+3.0%)
Dec 2023
$7.96B(-3.3%)
$3.44B(+5.8%)
Sep 2023
-
$3.25B(+7.8%)
Jun 2023
-
$3.01B(+8.1%)
Mar 2023
-
$2.78B(+6.8%)
Dec 2022
$8.23B(-15.1%)
$2.61B(+1.3%)
Sep 2022
-
$2.57B(-0.7%)
Jun 2022
-
$2.59B(+3.6%)
Mar 2022
-
$2.50B(-4.2%)
Dec 2021
$9.69B(+162.1%)
$2.61B(-0.6%)
Sep 2021
-
$2.63B(-11.0%)
Jun 2021
-
$2.95B(-6.7%)
Mar 2021
-
$3.17B(+11.5%)
Dec 2020
$3.70B(-5.4%)
$2.84B(+11.1%)
Sep 2020
-
$2.56B(+11.0%)
Jun 2020
-
$2.30B(+51.7%)
Mar 2020
-
$1.52B(-6.9%)
Dec 2019
$3.91B(-1.5%)
$1.63B(+7.2%)
Sep 2019
-
$1.52B(+11.0%)
Jun 2019
-
$1.37B(+4.9%)
Mar 2019
-
$1.31B(+5.8%)
Dec 2018
$3.97B(-4.5%)
$1.23B(-15.7%)
Sep 2018
-
$1.46B(+12.0%)
Jun 2018
-
$1.31B(+16.0%)
Mar 2018
-
$1.13B(+16.3%)
Dec 2017
$4.16B(+2.5%)
$968.28M(+16.5%)
Sep 2017
-
$830.94M(+25.4%)
Jun 2017
-
$662.50M(-12.0%)
Mar 2017
-
$752.85M(+0.6%)
Dec 2016
$4.05B(+95.3%)
$748.07M(+0.5%)
Sep 2016
-
$744.23M(-39.5%)
Jun 2016
-
$1.23B(-3.1%)
Mar 2016
-
$1.27B(+1.0%)
DateAnnualQuarterly
Dec 2015
$2.07B(-10.7%)
$1.26B(-4.4%)
Sep 2015
-
$1.31B(+5.6%)
Jun 2015
-
$1.24B(+12.9%)
Mar 2015
-
$1.10B(+8.6%)
Dec 2014
$2.32B(+69.1%)
$1.02B(+15.6%)
Sep 2014
-
$878.52M(+61.2%)
Jun 2014
-
$544.91M(+5.3%)
Mar 2014
-
$517.32M(-40.2%)
Dec 2013
$1.37B(-2.9%)
$864.62M(+6.7%)
Sep 2013
-
$810.07M(+10.3%)
Jun 2013
-
$734.18M(+13.4%)
Mar 2013
-
$647.37M(+17.4%)
Dec 2012
$1.41B(+2499.0%)
$551.57M(+43.3%)
Sep 2012
-
$385.01M(+28.1%)
Jun 2012
-
$300.44M(-8.2%)
Mar 2012
-
$327.14M(+64.3%)
Dec 2011
$54.44M(-11.1%)
$199.13M(+30.9%)
Sep 2011
-
$152.14M(+11.8%)
Jun 2011
-
$136.09M(+43.5%)
Mar 2011
-
$94.84M(+27.4%)
Dec 2010
$61.27M(-13.0%)
$74.46M(+132.1%)
Jun 2010
-
$32.08M(-17.2%)
Mar 2010
-
$38.74M(+4.8%)
Dec 2009
$70.44M(-4.2%)
$36.95M(+26.8%)
Sep 2009
-
$29.14M(-10.9%)
Jun 2009
-
$32.73M(-2.4%)
Mar 2009
-
$33.54M(-23.8%)
Dec 2008
$73.50M(-19.6%)
$44.00M(-36.9%)
Sep 2008
-
$69.70M(-0.7%)
Jun 2008
-
$70.20M(-41.1%)
Mar 2008
-
$119.25M(+2.7%)
Dec 2007
$91.46M(-25.6%)
$116.09M(-19.9%)
Sep 2007
-
$144.98M(-10.0%)
Jun 2007
-
$161.16M(+103.3%)
Mar 2007
-
$79.27M(-13.4%)
Dec 2006
$123.01M(-7.8%)
$91.56M(+191.8%)
Dec 2005
$133.40M
$31.38M

FAQ

  • What is Jazz Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual current assets year-on-year change?
  • What is Jazz Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly current assets year-on-year change?

What is Jazz Pharmaceuticals annual total current assets?

The current annual current assets of JAZZ is $4.63B

What is the all time high annual current assets for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual total current assets is $4.63B

What is Jazz Pharmaceuticals annual current assets year-on-year change?

Over the past year, JAZZ annual total current assets has changed by +$1.19B (+34.74%)

What is Jazz Pharmaceuticals quarterly total current assets?

The current quarterly current assets of JAZZ is $4.13B

What is the all time high quarterly current assets for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly total current assets is $4.63B

What is Jazz Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, JAZZ quarterly total current assets has changed by +$587.92M (+16.61%)
On this page